The Familial Female Mental Retardation/Epilepsy Gene Panel by NGS evaluates a comprehensive range of genes linked to inherited neurodevelopmental disorders affecting females, including intellectual disability and epilepsy. Using an EDTA blood sample, this test identifies genetic variants that influence brain development and neuronal function. Metropolis Healthcare uses advanced next-generation sequencing to deliver highly accurate and clinically significant results. The findings help guide early diagnosis, targeted interventions, and family counseling.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0195
Frequently Asked Questions (FAQ's):
What does the Familial Female Mental Retardation/Epilepsy Gene Panel include at Metropolis Healthcare?
It assesses multiple genes known to cause hereditary intellectual disability and epilepsy using advanced NGS technology.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences the relevant genes using high-precision next-generation sequencing.
Who should consider taking this test at Metropolis Healthcare?
Females with unexplained developmental delays, learning difficulties, seizures, or a family history of similar conditions may benefit from this panel.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is required for accurate DNA extraction and sequencing.
How long does Metropolis Healthcare take to provide the results?
Turnaround time depends on sequencing and analysis steps, with reports delivered promptly following detailed evaluation.
Why choose Metropolis Healthcare for this genetic panel?
Metropolis Healthcare ensures comprehensive gene coverage, strict quality checks, and clinically meaningful interpretation.
Does Metropolis Healthcare offer guidance after the test results?
Yes, results are accompanied by expert genetic insights to help clinicians interpret findings and plan further management.
Is this test suitable for pediatric cases at Metropolis Healthcare?
Yes, the panel is appropriate for children and adolescents when hereditary developmental or epileptic conditions are suspected.